Skip to content

SNN

Smith & Nephew plc

NYSE · Healthcare · Medical - Devices · GB

$27.56
−0.79%
Ask drillr

Year over year

Reported trailing growth

Revenue
+6.0%
EBITDA
-3.8%
EBIT
+7.3%
EPS
+31.6%
Free cash flow
+7.3%
Operating cash flow
+16.9%

Forward estimates

Based on analyst estimates

Revenue
-71.2%
EBITDA
-48.6%
EPS
-52.7%

Three-year CAGR

Revenue
+5.7%
EBITDA
+5.1%
EBIT
+20.8%
Net income
+41.0%
EPS
+42.9%
Free cash flow
+97.9%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026